13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001637359
Total reported value
$185.7M
$185.7M
13 檔
75.4%
The Q1 2025 SEC filing reveals that Omega Fund Management, LLC held a total portfolio value of $185.7M, covering 13 public equity positions.
In Q1 2025, Omega Fund Management, LLC displayed an active expansion posture, initiating 12 new positions and adding to 0 existing holdings, outstripping position reductions.
In terms of portfolio concentration, the top 5 core holdings (including KMTS, BCAX, BBNX) accounted for 75.4% of total reported equity market value during Q1 2025.
Top New Position Initiated
KMTS
市值: $44.8M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | KMTS | Kestra Medical Technologies, Ltd. | Stock-Other | 26.41% | +1.51% | — | |
| 2 | BCAX | Bicara Therapeutics Inc | Stock-Other | 16.95% | -0.02% | — | |
| 3 | BBNX | Beta Bionics Inc | Stock-Other | 14.36% | +3.03% | — | |
| 4 | NUVB | Nuvation Bio Inc | Stock-Other | 13.58% | +3.47% | — | |
| 5 | REPL | Replimune Group Inc | Stock-Other | 11.36% | -1.17% | EXIT | |
| 6 | UPB | Upstream Bio Inc | Stock-Other | 7.35% | — | — | |
| 7 | LXEO | Lexeo Therapeutics Inc | Stock-Other | 2.43% | — | — | |
| 8 | ALMS | Alumis Inc | Stock-Other | 2.37% | +0.40% | — | |
| 9 | ✓ | Ikena Oncology Inc | Stock-Other | 1.70% | — | — | |
| 10 | ✓ | Engene Holdings Inc | Stock-Other | 1.39% | -2.84% | — | |
| 11 | VTLUSD | Immunic Inc | Stock-Other | 1.15% | — | — | |
| 12 | SANA | Sana Biotechnology Inc | Stock-Other | 0.84% | +0.10% | — | |
| 13 | ✓ | Engene Holdings Inc | Stock-Other | 0.11% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | UPB | Upstream Bio Inc | -92.7% | — | Unchanged |
| 2 | KMTS | Kestra Medical Technologies, Ltd. | — | NEW | New buy |
| 3 | BCAX | Bicara Therapeutics Inc | — | NEW | New buy |
| 4 | BBNX | Beta Bionics Inc | — | NEW | New buy |
| 5 | NUVB | Nuvation Bio Inc | — | NEW | New buy |
| 6 | REPL | Replimune Group Inc | — | NEW | New buy |
| 7 | LXEO | Lexeo Therapeutics Inc | — | NEW | New buy |
| 8 | ALMS | Alumis Inc | — | NEW | New buy |
| 9 | ✓ | Ikena Oncology Inc | — | NEW | New buy |
| 10 | ✓ | Engene Holdings Inc | — | NEW | New buy |
| 11 | VTLUSD | Immunic Inc | — | NEW | New buy |
| 12 | SANA | Sana Biotechnology Inc | — | NEW | New buy |
| 13 | ✓ | Engene Holdings Inc | — | NEW | New buy |
According to official SEC Form 13F filings, Omega Fund Management, LLC reported a total U.S. public equity portfolio value of $185.7M across 13 disclosed positions in Q1 2025.
During Q1 2025, Omega Fund Management, LLC's top holdings by market value included KMTS (26.4%)、BCAX (16.9%)、BBNX (14.4%). The largest single position, KMTS, represented 26.4% of total portfolio value.
In Q1 2025, Omega Fund Management, LLC made 12 total portfolio adjustments, initiating 12 new buys, adding to 0 positions, trimming 0 holdings, and fully liquidating 0 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.